Note: All prices and reports are based on end of the day (EOD) data.
Granules India Limited (GRANULES)
What GRANULES does

Granules India Limited

What company does?Manufactures pharmaceutical products and active pharmaceutical ingredients (APIs)
Established1991
Entity typePrivate
HeadquartersIndia
SegmentB2B, B2C
Granules India Limited is a share market listed company in the Pharmaceuticals industry . It got listed on NSE on 20-JUN-2005 under the trading symbol GRANULES. On BSE it is listed under trading symbol GRANULES. The company operates in Pharmaceuticals , Active Pharmaceutical Ingredients (API) and Healthcare categories.

Company overview

Granules India Limited is a pharmaceutical manufacturing company based in Hyderabad, India. The company primarily focuses on the production of Active Pharmaceutical Ingredients (APIs), pharmaceutical formulation intermediates, and Finished Dosage Formulations (FDF) for various therapeutic areas including gastro-intestinal, pain management, anti-infectives, and central nervous system drugs.

One of the key aspects that sets Granules India apart from its competitors is its focus on vertically integrated operations which include research & development, manufacturing of APIs and FDFs, and marketing & distribution. This vertical integration allows the company to have better control over quality and costs throughout the entire value chain.

The company has also made significant strides in technological innovation by leveraging processes such as continuous processing techniques for API production. Continuous processing offers advantages such as improved efficiency, reduced waste generation, and enhanced product consistency compared to traditional batch processing methods.

In terms of collaborations and partnerships, Granules India has established strategic alliances with several global pharmaceutical companies for contract manufacturing services as well as co-development and licensing agreements for generic products. These partnerships have enabled the company to expand its presence in international markets while enhancing its product portfolio with high-value generics.

With a strong focus on quality compliance and regulatory standards along with an expanding global footprint through exports to over 45 countries worldwide including regulated markets like US, Europe, Japan etc., Granules India continues to solidify its position as a leading player in the pharmaceutical industry.

Disclaimer :

All prices or any other data provided here is based on previous day's closing price.

Trading or investing involves a high level of risk, including the loss of all of your investment. No information on our website should be interpreted as an investment / trading suggestion. We are not providing any kind of financial tips or recommendations. We just provide the data that you can analyse yourself and make your own decision. You are solely responsible for any of your action.

We are not SEBI registered analysts. Our website or any person associated with our website are not liable for any kind of losses, fees or charges etc.

We have tried our best to keep the data accuracy. But still we don't guarantee that our data is accurate and up to date. Verify the accuracy of data from official sources like NSE and BSE websites.

Any brand names, trademarks, or copyrighted materials used on this website are for informational purposes only. We disclaim any ownership or rights to such third-party copyrighted materials.

Stocklyzer

At stocklyzer, we provide financial tools, guides and data analysis to help you to make your decision in the financial market.

Contact us
Contact us for any kind of inquiry contact@stocklyzer.com Contact form
Stocklyzer.com © Copyright 2023. All Rights Reserved.